Advertisements



Why I"m Not Arbing The Fresenius / Akorn Deal

Why I"m Not Arbing The Fresenius / Akorn Deal.....»»

Category: topSource: seekingalphaAug 20th, 2017

Exclusive: Fresenius nears deal to acquire Akorn - sources

(Reuters) - German healthcare conglomerate Fresenius SE & Co KGaA is close to acquiring generic drugmaker Akorn Inc in an all-cash deal valuing the company at more than $4 billion, people familiar with the matter said on Monday......»»

Category: topSource: reutersApr 24th, 2017

Wall Street"s M&A Chatter From April 18: Akorn, Cardinal Health, Post-Weetabix, Nivalis Therapeutics-Alpine Immune

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday, April 18, 2017. Report Fresenius Deal to Acquire Akon is Imminent The Rumor: read more.....»»

Category: blogSource: benzingaApr 19th, 2017

Analyst: Akorn Could Be Sold For As Much As $34 Per Share, But There"s Double-Digits Downside If Deal Doesn"t Happen

Last week, Fresenius Kabi, a subsidiary of Fresenius Medical Care AG & Co. Lat.....»»

Category: blogSource: benzingaApr 11th, 2017

Akorn, Inc. (AKRX) Stock Soars on Possible Fresenius Deal

InvestorPlace - Stock Market News, Stock Advice.....»»

Category: topSource: investorplaceApr 10th, 2017

Focus On Europe: Will An Akorn - Fresenius Deal Pass Anti-Trust Scrutiny?

Focus On Europe: Will An Akorn - Fresenius Deal Pass Anti-Trust Scrutiny?.....»»

Category: topSource: seekingalphaApr 10th, 2017

Germany’s FMC to Pay $2 Billion for U.S. Home Dialysis Firm NxStage

It expects to close the deal next year. German dialysis services provider Fresenius Medical Care (FMC) freseni.....»»

Category: europeSource: fortuneAug 7th, 2017

Fresenius Medical (FMS) Acquires Akorn (AKRX) And Merck KGaA"s (MKGAF) Biosimilars Business - Slideshow

Fresenius Medical (FMS) Acquires Akorn (AKRX) And Merck KGaA"s (MKGAF) Biosimilars Business - Slideshow.....»»

Category: topSource: seekingalphaApr 27th, 2017

Fresenius snaps up Akorn, Merck KGaA"s biosimilars in separate deals

FRANKFURT (Reuter.....»»

Category: topSource: reutersApr 24th, 2017

Germany"s Fresenius Kabi to buy Akorn for $4.3 billion

Germany-based Fresenius Kabi will buy Ak.....»»

Category: topSource: marketwatchApr 24th, 2017

Akorn Shares Keep Moving Higher As Acquisition Rumored To Be "Imminent"

Akorn, Inc. (NASDAQ: AKRX) shares are drifting higher by 0.27 percent (about $0.10 per share) Wednesday after jumping 3.2 percent Tuesday following a report the company was on the verge of a buyout deal. read more.....»»

Category: blogSource: benzingaApr 19th, 2017

Fresenius Kabi in talks with Akorn for takeover

Akorn has five manufacturing facilities - three in US and one each in Switzerland & India.....»»

Category: topSource: business-standardApr 11th, 2017

Here"s Why Akorn Inc. Rose as Much as 12.8% Today

Management confirmed that it was in buyout talks with Fresenius Kabi for the potential sale of Akorn......»»

Category: topSource: foxnewsApr 10th, 2017

Fresenius Is A Highly Strategic Buyer For Akorn

Fresenius Is A Highly Strategic Buyer For Akorn.....»»

Category: topSource: seekingalphaApr 10th, 2017

Akorn Take-Out Chatter Supported By Trend Of Consolidation In Generic Drug Companies

A Bloomberg article Friday suggested that the European company Fresenius Medical Care AG & Co. (ADR) (NYSE: FMS) is considering a bid for Akorn, Inc. Lat.....»»

Category: blogSource: benzingaApr 10th, 2017

Wall Street"s M&A Chatter From April 7-9: 21st Century Fox, Akorn, BioTelemetry-LifeWatch, Intrawest Resorts

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday, April 7 through Sunday, April 9, 2017. Fresenius in Talks for Acquisition of Akorn The Talks: read more.....»»

Category: blogSource: benzingaApr 10th, 2017

Germany"s Fresenius in Talks to Buy U.S. Drug Maker Akorn

German health-care company Fresenius is in discussions to acquire U.S. firm Akorn, a maker of generic drugs that is currently valued at about $3.7 billion......»»

Category: smallbizSource: wsjApr 9th, 2017

Germany"s Fresenius in talks to buy generic drugmaker Akorn

(Reuters) - German healthcare group Fresenius SE & Co KGaA said on Friday that it was in talks with the generic drugmaker Akorn Inc for a potential takeover......»»

Category: topSource: reutersApr 7th, 2017

Why Akorn, Inc. (AKRX) Shares Spiked Higher

Akorn, Inc. (NASDAQ:AKRX) shares have surged 18% on Friday after Bloomberg reported that its sources say Fresenius SE ‘is weighing a b.....»»

Category: topSource: insidermonkeyApr 7th, 2017

Akorn shares jump 19% after report Germany"s Fresenius mulling a bid

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 7th, 2017

Akorn shares surge 20% on report Germany"s Fresenius is mulling a bid

Shares of generic drug company Akorn Inc. rallied 20% Friday, after Bloomberg reported that Germany's Fresenius SE & Co. KGaA is mulling a bid. Bloomberg said the two companies are in talks, but have .....»»

Category: topSource: marketwatchApr 7th, 2017